Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on February 13, 2013. The report announces the issuance of a press release detailing financial results for the fiscal quarter ended December 31, 2012.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the body text. It references the press release for the full announcement of results.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The report contains statements regarding intentions, beliefs, and expectations, including a planned spin-off of a separate public company.
- Key Risks: Management highlights uncertainties associated with effecting the spin-off and the Board of Directors' discretion to delay or cancel the transaction prior to execution.
- Disclaimer: Actual outcomes may differ materially from forecasts due to risks discussed in the Annual Report on Form 10-K.
Investor Verification Checklist
- Verify the specific financial results (revenue, net income, cash position) in the press release attached as Exhibit 99.1.
- Confirm the current status and timeline of the planned spin-off mentioned in the forward-looking statements.
- Review the Annual Report on Form 10-K for a comprehensive list of risk factors affecting future performance.